Aging, Energy, and Oxidative Stress in Neurodegenerative Diseases
Overview
Authors
Affiliations
The etiology of neurodegenerative diseases remains enigmatic; however, evidence for defects in energy metabolism, excitotoxicity, and for oxidative damage is increasingly compelling. It is likely that there is a complex interplay between these mechanisms. A defect in energy metabolism may lead to neuronal depolarization, activation of N-methyl-D-aspartate excitatory amino acid receptors, and increases in intracellular calcium, which are buffered by mitochondria. Mitochondria are the major intracellular source of free radicals, and increased mitochondrial calcium concentrations enhance free radical generation. Mitochondrial DNA is particularly susceptible to oxidative stress, and there is evidence of age-dependent damage and deterioration of respiratory enzyme activities with normal aging. This may contribute to the delayed onset and age dependence of neurodegenerative diseases. There is evidence for increased oxidative damage to macromolecules in amyotrophic lateral sclerosis, Huntington's disease, Parkinson's disease, and Alzheimer's disease. Potential therapeutic approaches include glutamate release inhibitors, excitatory amino acid antagonists, strategies to improve mitochondrial function, free radical scavengers, and trophic factors. All of these approaches appear promising in experimental studies and are now being applied to human studies.
Unveiling the Origin of Copper Accumulation in Plasma with Aging.
Wang W, Lu D, Yang H, Chen Z, Ling W, Song S Environ Health (Wash). 2025; 3(1):58-67.
PMID: 39839250 PMC: 11744393. DOI: 10.1021/envhealth.4c00096.
Ahlawat A, Walia V, Garg M Acta Neurol Belg. 2025; .
PMID: 39762668 DOI: 10.1007/s13760-024-02706-7.
Gut Microbiota and Immune System Dynamics in Parkinson's and Alzheimer's Diseases.
Kustrimovic N, Balkhi S, Bilato G, Mortara L Int J Mol Sci. 2024; 25(22).
PMID: 39596232 PMC: 11595203. DOI: 10.3390/ijms252212164.
El Din R, Thabit S BMC Complement Med Ther. 2024; 24(1):377.
PMID: 39468600 PMC: 11514749. DOI: 10.1186/s12906-024-04670-4.
Xie W, Koppula S, Kale M, Ali L, Wankhede N, Umare M Front Pharmacol. 2024; 15:1469053.
PMID: 39309002 PMC: 11413492. DOI: 10.3389/fphar.2024.1469053.